High-dose selenium for the mitigation of radiation injury: A pilot study in a rat model

Radiation Research

Volumn 171, Issue 3, 2009, Pages 368-373

  Sieber, Fritz ^a,b   Muir, Sarah A ^a   Cohen, Eric P ^b   North, Paula E ^b   Fish, Brian L ^b   Irving, Amy A ^b   Mäder, Marylou ^b   Moulder, John E ^b  

^a CHILDREN S HOSPITAL OF WISCONSIN   (United States)

^b MEDICAL COLLEGE OF WISCONSIN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

SELENOMETHIONINE; SODIUM SELENITE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DIET SUPPLEMENTATION; DISEASE SEVERITY; DRUG EFFICACY; DRUG MEGADOSE; DRUG SAFETY; HISTOPATHOLOGY; KIDNEY FAILURE; KIDNEY INJURY; MALE; NONHUMAN; PILOT STUDY; PRIORITY JOURNAL; RADIATION EXPOSURE; RADIATION INJURY; RAT; UREA NITROGEN BLOOD LEVEL; WHOLE BODY RADIATION;

ADMINISTRATION, ORAL; ANIMALS; BLOOD UREA NITROGEN; DIETARY SUPPLEMENTS; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG TOXICITY; ENVIRONMENTAL EXPOSURE; KIDNEY; MALE; PILOT PROJECTS; RADIATION INJURIES, EXPERIMENTAL; RATS; SODIUM SELENITE;

ANIMALIA; RATTUS;

EID: 61849152902     PISSN: 00337587     EISSN: None     Source Type: Journal    
DOI: 10.1667/0033-7587-171.3.368     Document Type: Article

References (22)

1. H. B. Stone, J. E. Moulder, C. N. Coleman, K. K. Ang, M. S. Ansch-er, M. H. Barcellos-Hoff, W. S. Dynan, J. R. Fike, D. J. Grdina and D. Zaharevitz, Models for evaluating agents intended for the prophylaxis, mitigation and treatment of radiation injuries. Report of an NCI workshop, December 3-4, 2003. Radiat. Res. 162, 711-728 (2004).
2. E. P. Cohen, B. L. Fish, M. Sharma, X. A. Li and J. E. Moulder, The role of the angiotensin II type-2 receptor in radiation nephropathy. Transl. Res. 150, 106-115 (2007).
3. J. E. Moulder and B. L. Fish, Late toxicity of total body irradiation with bone marrow transplantation in a rat model. Int. J. Radiat. Oncol. Biol. Phys. 16, 1501-1509 (1989).
4. J. E. Moulder, B. L. Fish and E. P. Cohen, Treatment of radiation nephropathy with ACE inhibitors. Int. J. Radiat. Oncol. Biol. Phys. 27, 93-99 (1993).
5. E. P. Cohen, B. L. Fish and J. E. Moulder, The renin-angiotensin system in experimental radiation nephropathy. J. Lab. Clin. Med. 139, 251-257 (2002).
6. L. Flohe, W. A. Gunzler and H. H. Schock, Glutathione peroxidase: a selenoenzyme. FEBS Lett. 32, 132-134 (1973).
7. D. L. Hatfield, M. J. Berry and V. N. Gladyshev, Eds., Selenium. Its Molecular Biology and Role in Human Health. Springer, New York, 2006.
8. N. J. Traynor, R. C. McKenzie, G. J. Beckett and N. L. Gibbs, Selenomethionine inhibits ultraviolet radiation-induced p53 transacti-vation. Photodermatol. Photoimmunol. Photomed. 22, 297-303 (2006).
9. E. Kowalska, S. A. Narod, T. Huzarski, S. Zajaczek, J. Huzarska, B. Gorski and J. Lubinski, Increased rates of chromosome breakage in BRCA1 carriers are normalized by oral selenium supplementation. Cancer Epidemiol. Biomarkers Prev. 14, 1302-1306 (2005).
10. J. L. Fischer, J. K. Lancia, A. Mathur and M. L. Smith, Selenium protection from DNA damage involves a Rfl1/p53/Brca1 protein complex. Anticancer Res. 26, 899-904 (2006).
11. H. Blessing, S. Kraus, P. Heindl, W. Bal and A. Hartwig, Interaction of selenium compounds with zinc finger proteins involved in DNA repair. Eur. J. Biochem. 271, 3190-3199 (2004).
12. J. L. Fischer, E. M. Mihelc, K. E. Pollok and M. L. Smith, Chemo-therapeutic selectivity conferred by selenium: a role for p53-depen-dent DNA repair. Mol. Cancer Ther. 6, 355-361 (2007).
13. S. O. Yoon, M. M. Kim, S. J. Park, D. Kim, J. Chung and A. S. Chung, Selenite suppresses hydrogen peroxide-induced cell apoptosis through inhibition of ASK1/JNK and activation of P13-K/Akt pathways. FASEB J. 16, 111-113 (2002).
14. J. F. Weiss, V. Srinivasan, K. S. Kumar and M. R. Landauer, Radio-protection by metals: selenium. Adv. Space Res. 12, 223-231 (1992).
15. J. F. Weiss and M. R. Landauer, Radioprotection by antioxidants. Ann. NY Acad. Sci. 899, 44-60 (2000).
16. J. Büntzel, R. Weinaug, M. Glatzel, D. Fröhlich, O. Micke, P. Schüll- er and K. Küttner, Sodium selenite in the treatment of interstitial post- irradiation edema of the head and neck area. Trace Elem. Electrolytes 191, 33-37 (2002).
17. O. Micke, F. Bruns, R. Mücke, U. Schafer, M. Glatzel, A. F. DeVries, K. Schonekaes, K. Kisters and J. Büntzel, Selenium in the treatment of radiation-associated secondary lymphedema. Int. J. Radiat. Oncol. Biol. Phys. 56, 40-49 (2003).
18. J. Fraunholz, L. Jüling-Phlit and H. Böttcher, Influence of selenium on acute mucositis in radiochemotherapy of head and neck tumors. Trace Elem. Electrolytes 18, 98-99 (2001).
19. V. A. Knizhnikov, N. K. Shandala, V. A. Komleva, V. A. Knyashev and V. A. Tutelyan, The effect of dietary levels of selenium on radiation resistance and radiation-induced carcinogenesis. Nutr. Res. 16, 505-516 (1996).
20. J-Y. Yeh, B. R. Ou, Q-P. Gu and P. D. Whanger, Influence of gender on selenoprotein W, glutathione peroxidase and selenium in tissues of rats. Comp. Biochem. Physiol. B Biochem. Mol. Biol. 119, 151-155 (1998).
21. E. P. Cohen, W. R. Drobyski and J. E. Moulder, Significant increase in end-stage renal disease after hematopoietic stem cell transplantation. Bone Marrow Transpl. 39, 571-572 (2007).
22. E. P. Cohen, W. F. Piering, C. Kabler-Babbitt and J. E. Moulder, End-stage renal disease (ESRD) after bone marrow transplantation: Poor survival compared to other causes of ESRD. Nephron 78, 408-412 (1998).